SCHEMBL26548539

SCHEMBL26548539

CC(C)Nc1cc(-n2ccnc2)ccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.47
CYP11B1 P15538 3/20 0.43
CYP11B2 P19099 3/20 0.43
CYP19A1 P11511 3/20 0.43
IDO1 P14902 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.42
CYP3A4 P08684 3/20 0.42
TSHR P16473 2/20 0.42
NPC1 O15118 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
ENPP2 Q13822 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
NOTUM Q6P988 1/20 0.40
HTT P42858 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26547633 0.79 PCSK9 (0.54) CYP11B1CYP11B2CYP19A1CYP3A4TSHR
SCHEMBL26815031 0.76 CYP11B1 (0.50) CYP11B1CYP11B2CYP19A1IDO1NCOA3
SCHEMBL13034788 0.76 TSHR (0.51) TSHRNPC1HSD17B10MAPK1
SCHEMBL24782873 0.76 LMNA (0.55) CYP19A1CYP3A4TSHRNPC1HSD17B10
SCHEMBL27368425 0.74 CYP3A4 (0.50) CYP11B1CYP11B2CYP19A1IDO1NCOA3
SCHEMBL26551517 0.73 HRH4 (0.47) HRH4CYP19A1CYP3A4CYP1A2CYP2D6
SCHEMBL950968 0.72 CYP3A4 (0.52) CYP11B1CYP11B2CYP19A1IDO1NCOA3
SCHEMBL4708730 0.70 IDO1 (0.59) CYP11B1CYP11B2CYP19A1IDO1NCOA3
SCHEMBL19719157 0.70 LMNA (0.51) CYP11B1CYP11B2CYP19A1CYP3A4TSHR
SCHEMBL25493009 0.70 HRH4 (0.68) HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed